In an attempt to find the risk of relapse and factors predictive of risk of relapse, 97 children with epilepsy, withdrawn from their medication, followed in our outpatient clinic from 1990 to 1995 were included in this study. The overall relapse rate was 20.6%. All relapses occurred within 2 years after withdrawal started. Female gender, age at onset of seizures of more than 2 years, and the duration of withdrawal were found to be significant risk factors in relapse rate following univariate analysis. However, gender was not found to be significant in multivariate analysis. All other factors, including the duration of seizures prior to starting antiepileptic drug (AED) treatment, the number of seizure before the start of AED treatment, the period between AED induction and control of seizures, diagnostic yield from electroencephalogy (EEG) at diagnosis, the number of seizures after the onset of AED therapy, length of seizure-free period, aetiology of the seizures, a history of epilepsy in the immediate family, or previously experienced febrile convulsions were not significant factors in relapse rate. Significant risk factors for relapse rate also significantly affected relapse time. We conclude that when AED therapy is withdrawn from children with uncomplicated epilepsy, as in our patients, the two important risk factors, age at onset of seizures and the duration of withdrawal, can predict a poor prognosis with a higher relapse rate: this needs taking into consideration.
INTRODUCTION
Long-term adverse effects of antiepileptic drugs (AEDs) are well known, particularly in children 1 . When making a decision to discontinue AEDs in epileptic children after a sufficient seizure-free period, long-term side-effects of continued medication as well as various factors associated with the risk of relapse must be taken into consideration.
In recent years, several studies have been conducted to determine the risk of relapse after AED withdrawal: there is, however, no general agreement on criteria that can predict safe discontinuation or subsequent recurrence of seizures, particularly in children with uncomplicated epileptic seizures [2] [3] [4] [5] [6] .
This study was designed to identify the risk factors associated with relapse after AED withdrawal in children with uncomplicated epileptic seizures.
MATERIALS AND METHODS
This study was carried out on patients with epilepsy followed in our outpatient clinic in the Department of Paediatric Neurology. One hundred and seventynine patients who were first admitted to our clinic between 1991 and 1995 and whose anticonvulsant medications had been stopped were considered for investigation. All patients had at least two afrebrile seizures before the age of 12, which were not due to metabolic or infectious disease of the central nervous system (CNS). Patients with neonatal convulsions, progressive CNS disorder, any inborn error of metabolism or febrile convulsion were excluded: 97 patients were not excluded from this study (58 boys, 39 girls). Age at onset of first seizure varied from 2 months to 12 years (mean ± SD : 4.5 ± 3.3 years). Age during the study period varied from 4 to 20 years (mean ± SD : 12.5 ± 3.6 years). The patients who did not have a recurrence had been followed for at least 2 years (max. 48 months).
Seizures were classified according to the classification of seizures of the International League Against Epilepsy 7 . Of the 25 children (26% with generalized seizures) 6 had tonic, 15 had tonic-clonic, 2 had absence, and 2 had myoclonic seizures. Ten children (10.3%) had simple partial seizures, 43 chil-dren (44.3%) had complex partial seizures and 19 children (19.5%) had secondary generalized seizures. Seven out of 10 patients with simple partial seizures were diagnosed as having benign childhood epilepsy with centrotemporal spikes (benign rolandic epilepsy). Of two absence seizures, one was typical of juvenile absence epilepsy and the other atypical with the Lennox-Gastaut syndrome. Two children with myoclonic seizures had infantile spasms. Of the total of 43 patients with complex partial seizures, 2 patients were diagnosed as having benign occipital lobe epilepsy. Because of the relatively small number of patients in some seizure types and epileptic syndromes, seizure types were merged into generalized and partial seizures. Hence, 25 patients (26%) had generalized seizures and 72 patients (74%) partial seizures.
The patients were divided into various groups based on the risk factors for relapse (Table 1 ). All but three patients had one or more interictal electroencephalogy (EEG) recordings performed at diagnosis. In these three patients and in patients with a normal EEG, diagnosis and determination of seizure type were made clinically. An EEG recorded within a year before withdrawal was accepted as the withdrawal EEG. Since 93 of the patients (96%) had a normal withdrawal EEG and the other four patients had an EEG with only paroxysmal slow waves, withdrawal EEGs were excluded from the analysis. A withdrawal period of less than 1 month was categorized as a sudden discontinuation, and was excluded from analysis. Fifty-seven patients (58%) were on phenobarbitone, 19 (20%) on carbamazepine, 10 (10%) on valproic acid, 9 (10%) on diphenylhydantoin, and 2 (2%) on more than one AED.
Patients were aetiologically classified according to the method described by Hauser and Kurland 8 . If the patients had a static encephalopathy from birth or acquired prior to the first seizure or had any prior neurological insult such as stroke or head trauma (associated with a depressed skull fracture, loss of consciousness for longer than 30 minutes or intracranial bleeding), they were classified as 'remote symptomatic'. In addition, those with mental retardation were estimated clinically, not by formal psychological testing results. According to this clinical estimation some patients were accepted that had a mild mental retardation. None of the patients had moderate to severe mental retardation. If a patient had a history of stage II and III hypoxic-ischaemic encephalopathy at birth, the patient was included in the remote symptomatic group. All the other patients with unprovoked seizures were classified as idiopathic.
Initially, clinically a 4-year seizure-free period plus an EEG without active epileptic discharges within a year before withdrawal was used as the criteria for AED discontinuation. Later, 2-3 years of seizure freedom and a normal EEG were taken as criteria for withdrawal, relying on recent literature [9] [10] [11] . Family history was considered 'positive' if there was a history of one or more unprovoked seizures in the immediate family (parents or sibling).
The factors used in evaluation included gender, age at onset, duration of seizures prior to starting the AED, number of seizures prior to starting the AED, duration between the onset of seizures and starting the AED, number of seizures after starting the AED, length of the seizure-free period, duration of withdrawal (tapering period), aetiology, nature of EEG support for the diagnosis, family history of epilepsy and a history of previous febrile convulsions.
The BMDP and SPSSx Statistical Packages were used in the analysis. The chi-squared test or Fisher's exact test was used in assessing the univariate associations between categorical responses. Factors that might simultaneously have important effects on relapse rate and relapse time were determined by the methods of multivariate logistic regression and Cox proportional hazard models, respectively 12, 13 .
RESULTS
Seizures after withdrawal occurred in 20 children (20.6%) ( Fig. 1 ) of whom 6 (30%) had a relapse within the first 3 months, 9 (45%) within the first 6 months, 14 (70%) within the first 12 months, all within the first 2 years after the start of withdrawal.
The relapse rate for patients whose first seizure occurred before the age of 2 was 5.3%, whereas it was 30.5% for children whose seizures began after the age of 2. This difference was statistically significant (P < 0.05) (Fig. 2) . The relapse rates according to gender were 13.8% for boys, 30.8% for girls and the difference was statistically significant in univariate analysis (P < 0.05) (Fig. 3) .
The relapse rate for the patients whose medication was withdrawn gradually over 2-5 months was 38.9%, whereas it was 16.5% for the patients whose drug was withdrawn over more than 5 months. The difference was statistically significant (P < 0.05) (Fig. 4) . No other factors were statistically significant.
Since some groups of seizure types included a small number of patients, we could not evaluate the difference between these groups in terms of relapse rate, but could evaluate the difference between the relapse rates for patients with generalized and partial seizures: it was not significant (P > 0.05), (Table 1 ). All seven patients with benign rolandic epilepsy did not relapse. One of two children with benign occipital lobe epilepsy relapsed but the other did not. The children with infantile spasm (n = 2), Lennox-Gastaut syndrome (n = 1) and juvenile absence epilepsy (n = 1) did not have a recurrence. Because these epileptic syndromes include a very small number of patients, we were unable to evaluate them in terms of relapse rate.
Multivariate Analysis
In order to investigate the influence of several factors simultaneously on the relapse rate, multivariate logistic regression was applied. An age of onset of more than 2 years, and duration of AED withdrawal less than 6 months were found to be significant risk factors in predicting a poor outcome. Gender was found not to be a significant risk factor by multivariate analysis ( Table 2 ). The risk factors affecting relapse rate (age at onset and the length of withdrawal) were also found to significantly affect relapse time (P < 0.05) ( Table 3 ). 
DISCUSSION
The overall relapse rate was 20.6% in our study. Reported rates have varied from 22.4% to 40% in other studies 3, 5, 9, 14, 15 . This discrepancy may be due to the heterogeneity of the population, follow-up periods and statistical methods used. Our relatively lower relapse rate can be explained by most of the EEGs being normal before withdrawal, by not including patients with neurological deficits or with moderate to severe mental retardation and not including types of epilepsy known to have a poor prognosis on drug withdrawal such as juvenile myoclonic or severe infantile myoclonic epilepsy. All recurrences occurred within the first 2 years. In other studies, 85-90% of recurrences were reported within 2 years 3, 5, 16 , suggesting all patients being withdrawn should be followed clinically and electrographically for at least the first 2 years after drug withdrawal. We found that being female was a significant risk factor with a 30.8% relapse rate on univariate analysis. This finding is in agreement with some studies 17, 18 , although most other studies have reported the opposite 3, 10, 13, 14 . Eighty-four percent of our female patients at the onset of seizures were more than 2 years old. This may explain the reason that the female gender is found to be a significant risk factor in our study. In Dooley et al. 's study, 17 the female gender was reported to be a significant risk factor in both univariate and multivariate analysis. This discrepancy may be explained by differences in study populations and some features such as age at seizure onset, the state of the EEG at the time of withdrawal and seizure type.
Some authors have, like us, also reported age at onset as a significant risk factor for recurrence 3, 5, 11, 12 . But there are others who did not 2, 14, 19 . A young age at onset was reported as a poor prognostic factor in some studies 3, 4, 20 , but as a good prognostic factor in others as in our study 15, 16, 21 : differences in the populations studied appears to explain this discrepancy. In addition, some factors found to be significant by univariate analysis may be found not to be significant by multivariate analysis as in Emerson's 3 and our study. We found age at onset of less than 2 years to be a good prognostic factor. However, our population did not include some types of epilepsy with a poor prognosis, such as infantile spasms or the severe myoclonic epilepsies of infancy.
We did not find any significant difference between generalized or partial onset seizures. Some previous studies 2, 19, 22 have reported that seizure type is a significant risk factor, whereas others 3, 5, 9, 14 did not. Our own studies and these latter studies did not separate out patients with benign epileptic syndromes. For example, seven of our patients with simple partial seizures had benign rolandic epilepsy: they had no recurrence.
Seizure frequency, the time elapsed before the onset of AED treatment, the total number of seizures and the time elapsed between starting AED treatment and control of seizures were all considered as measures of epilepsy severity. None of these factors were found to be a significant risk factor for relapse. In one study 10 , seizure frequency and the time elapsed before starting AED treatment; in two studies 2, 14 , the time elapsed between starting AED treatment and seizure control, in two studies 3, 19 , the number of seizures before seizure control, were reported to be significant risk factors. There seems to be no concensus as to the significance of the above factors on the risk of relapse.
A degree of mental retardation (moderate to severe) and/or any neurological deficit, may have an effect on relapse rate as shown in some studies 4, 10, 14, 17 , but not in this study or others 2, 3, 16 . However, our remote symptomatic group only included patients with mild degrees of mental retardation.
One of the factors about which there is most disagreement is seizure-free period. We did not find any significant difference in relapse rate for different seizure-free periods in agreement with some studies 2, 4, 10 , but not another 11 . Our study suggests that 2 years seizure free may be sufficient as a treatment period. Certainly this conclusion is valid for populations including patients with a normal EEG at the time of withdrawal, without moderate to severe mental retardation with no neurological abnormality, and without an epilepsy syndrome with a poor prognosis. We could not evaluate seizure-free periods of less than 2 years because of an insufficient number of patients. Peters et al. 23 reported no significant difference with respect to a relapse rate of between 6 and 12 months of seizure freedom in uncomplicated epileptic children. Thus, because they did not compare other seizure-free periods (18, 24 , 36 months) they could not be certain that 6 months of seizure freedom was sufficient for starting drug withdrawal. Two studies about withdrawal were recently reported by Gunnar et al. and Dooley et al. 17, 24 in which a seizure-free period of just 1 year was found to be a sufficient treatment period for epilepsy with simple partial seizures and with benign centrotemporal spikes in a population of uncomplicated patients.
A history of epilepsy in the immediate family or antecedent febrile convulsions were not reported as significant risk factors in some studies 4, 10 (as in this study), but in other studies these were reported to be significant risk factors 5, 14 .
EEG features at diagnosis do not predict the prognosis for relapse as both ourselves and others have reported 20, 26, 27 . Ninety-six percent of our patients at withdrawal had a normal EEG. In the remainder, there were minor abnormalities (such as episodic slow wave activity). On our multivariate analysis, age at onset and the length of withdrawal, but not female gender, were also found to be significant risk factors. As explained above, 87% of our female patients were more than 2 years of age at the onset of seizure, suggesting that relapse was affected by age at onset not by female gender. Emerson et al. 3 also reported factors of mental retardation, age at onset, frequency of seizures and EEG pattern to be significant for relapse rate in univariate analysis, but only EEG pattern at withdrawal and frequency of seizures were significant in multivariate analysis.
The two risk factors which were found to significantly affect relapse rate, age at onset and the duration of withdrawal also had an effect on relapse time. The relapse time for patients with these two factors was shorter than that of others. Most studies have also reported that risk factors that affect relapse rate also affect relapse time 3, 15, 16 .
In conclusion, the overall relapse rate was 20.6% among young patients with epilepsy whose medication was withdrawn. All the relapses occurred within 2 years. When contemplating AED withdrawal in patients with uncomplicated epilepsy (as in our patients), it should be remembered that 2 important risk factors, age at onset of seizure of more than two years and a duration of withdrawal of less than 6 months, predict a poor prognosis with a higher relapse rate.
